ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 237

$802K Total Retail Price of All Prescriptions

Rank: 17 out of 237

763 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Delaware
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 763 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 763 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Delaware
METFORMIN HCL 501 354 121 1 8
ATORVASTATIN CALCIUM 499 376 133 2 4
AMLODIPINE BESYLATE 425 380 103 3 5
LISINOPRIL 390 278 100 4 1
LEVOTHYROXINE SODIUM 384 310 74 5 2
PRAVASTATIN SODIUM 320 276 89 6 11
GLIMEPIRIDE 258 213 53 7 37
SIMVASTATIN 250 167 73 8 3
HYDROCHLOROTHIAZIDE 223 190 61 9 9
TRAMADOL HCL 210 146 63 10 16
LOSARTAN POTASSIUM 198 169 51 11 20
OMEPRAZOLE 194 117 55 12 6
CRESTOR 191 144 40 13 17
FUROSEMIDE 185 168 68 14 7
ALPRAZOLAM 177 120 42 B 15 10
ATENOLOL 175 149 50 16 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 147 43 17 23
CLOPIDOGREL 154 135 35 18 25
FELODIPINE ER 152 147* 34 19 152
DOXAZOSIN MESYLATE 128 123* 30 20 103
METOPROLOL SUCCINATE 119 92 33 21 13
ALLOPURINOL 107 102* 29 22 43
HYDROCODONE-ACETAMINOPHEN 102 67 24 S3 23 27
CARVEDILOL 93 81 31 24 24
ZETIA 91 63 17 25 89
PAROXETINE HCL 86 68 19 26 76
GABAPENTIN 85 56 21 27 14
ZOLPIDEM TARTRATE 80 64 21 28 18
NOVOFINE 32 77 37 20 29 210
AMLODIPINE BESYLATE-BENAZEPRIL 77 72* 21 29 80
SYNTHROID 73 60 16 31 35
FLUTICASONE PROPIONATE 72 29 28 32 33
TRIAMTERENE-HCTZ 70 43 22 33 98
LOSARTAN-HYDROCHLOROTHIAZIDE 69 54 21 34 83
POTASSIUM CHLORIDE 68 52 22 35 38
LANTUS SOLOSTAR 66 39 22 36 72
FENOFIBRATE* 65 <11 <11 37 81
VALSARTAN-HYDROCHLOROTHIAZIDE 65 60* 15 37 58
ISOSORBIDE MONONITRATE ER 64 59* 13 39 70
PREDNISONE 64 51 32 39 50
TAMSULOSIN HCL 64 53 19 39 29
CLONAZEPAM 61 49 11 B 42 49
OXYCODONE HCL 60 <11 15 S2 43 28
DIOVAN 60 47 16 43 31
SPIRIVA 58 53* 12 45 62
OXYCODONE HCL-ACETAMINOPHEN 57 <11 <11 S2 46 60
JANUVIA 56 <11 <11 47 66
DONEPEZIL HCL 56 56 13 47 34
FLUOXETINE HCL 53 39 18 49 63
SERTRALINE HCL 52 32 13 50 19
ACETAMINOPHEN-CODEINE 51 30 14 S3 51 136
PROAIR HFA 50 28 24 52 40
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.